Huons Global Co., Ltd.

KOSDAQ:A084110 Stock Report

Market Cap: ₩508.5b

Huons Global Past Earnings Performance

Past criteria checks 2/6

Huons Global's earnings have been declining at an average annual rate of -20%, while the Pharmaceuticals industry saw earnings growing at 7.5% annually. Revenues have been growing at an average rate of 12.6% per year. Huons Global's return on equity is 8.3%, and it has net margins of 4.5%.

Key information

-20.0%

Earnings growth rate

-20.0%

EPS growth rate

Pharmaceuticals Industry Growth11.3%
Revenue growth rate12.6%
Return on equity8.3%
Net Margin4.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenues Not Telling The Story For Huons Global Co., Ltd. (KOSDAQ:084110) After Shares Rise 26%

Dec 14
Revenues Not Telling The Story For Huons Global Co., Ltd. (KOSDAQ:084110) After Shares Rise 26%

Huons Global (KOSDAQ:084110) Takes On Some Risk With Its Use Of Debt

Dec 04
Huons Global (KOSDAQ:084110) Takes On Some Risk With Its Use Of Debt

Subdued Growth No Barrier To Huons Global Co., Ltd. (KOSDAQ:084110) With Shares Advancing 26%

Sep 24
Subdued Growth No Barrier To Huons Global Co., Ltd. (KOSDAQ:084110) With Shares Advancing 26%

Is Huons Global Co., Ltd. (KOSDAQ:084110) An Attractive Dividend Stock?

May 06
Is Huons Global Co., Ltd. (KOSDAQ:084110) An Attractive Dividend Stock?

Huons Global's (KOSDAQ:084110) Earnings Are Weaker Than They Seem

Mar 18
Huons Global's (KOSDAQ:084110) Earnings Are Weaker Than They Seem

Do Huons Global's (KOSDAQ:084110) Earnings Warrant Your Attention?

Mar 12
Do Huons Global's (KOSDAQ:084110) Earnings Warrant Your Attention?

How Much Of Huons Global Co., Ltd. (KOSDAQ:084110) Do Insiders Own?

Feb 22
How Much Of Huons Global Co., Ltd. (KOSDAQ:084110) Do Insiders Own?

We Think Huons Global (KOSDAQ:084110) Can Manage Its Debt With Ease

Feb 04
We Think Huons Global (KOSDAQ:084110) Can Manage Its Debt With Ease

Huons Global Co., Ltd. (KOSDAQ:084110) Pays A ₩400 Dividend In Just Three Days

Dec 24
Huons Global Co., Ltd. (KOSDAQ:084110) Pays A ₩400 Dividend In Just Three Days

Huons Global Co., Ltd.'s (KOSDAQ:084110) Stock Has Fared Decently: Is the Market Following Strong Financials?

Dec 22
Huons Global Co., Ltd.'s (KOSDAQ:084110) Stock Has Fared Decently: Is the Market Following Strong Financials?

Here's What You Should Know About Huons Global Co., Ltd.'s (KOSDAQ:084110) 1.3% Dividend Yield

Nov 29
Here's What You Should Know About Huons Global Co., Ltd.'s (KOSDAQ:084110) 1.3% Dividend Yield

Revenue & Expenses Breakdown

How Huons Global makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A084110 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24811,00836,506252,04168,910
30 Jun 24802,20344,936247,42567,231
31 Mar 24786,29742,621244,05160,058
31 Dec 23758,38038,384235,29259,588
30 Sep 23731,422-47,827229,30054,596
30 Jun 23708,371-53,529230,75250,565
31 Mar 23682,264-58,764223,05152,893
31 Dec 22664,365-59,876219,09952,545
30 Sep 22645,134171216,74053,894
30 Jun 22622,996-744208,63352,208
31 Mar 22599,0693,172205,09048,798
31 Dec 21574,6484,883194,75245,815
30 Sep 21563,82633,394182,12842,821
30 Jun 21555,58340,096174,68940,843
31 Mar 21538,06843,053164,46038,828
31 Dec 20523,04842,696158,22738,428
30 Sep 20503,60533,954157,41537,611
30 Jun 20482,61530,103152,04236,472
31 Mar 20463,79826,715147,74836,146
31 Dec 19449,42326,657144,93434,457
30 Sep 19427,63023,056140,25332,717
30 Jun 19411,03426,504134,57231,829
31 Mar 19395,77029,005129,20429,713
31 Dec 18378,68729,454124,17228,597
30 Sep 18359,53234,660119,02726,765
30 Jun 18345,78831,085114,18726,024
31 Mar 18335,68528,826108,27626,475
31 Dec 17323,96125,953104,78126,900
30 Sep 17314,72220,61998,35927,395
30 Jun 17282,51316,28888,20124,682
31 Mar 17222,27511,61067,08119,260
31 Dec 16163,7128,28344,98413,469
30 Sep 16107,5424,91025,7047,824
30 Jun 1672,5273,43113,2014,661
31 Mar 1667,8692,15412,1624,181
31 Dec 1565,4481,37211,6594,243
30 Sep 1598,6337,22123,3147,084
30 Jun 15126,35511,71132,8949,561
31 Mar 15153,39316,55041,78011,101
31 Dec 14182,34320,93350,38012,673
30 Sep 14175,24918,40745,75911,817
30 Jun 14171,29519,01342,79911,920
31 Mar 14165,53318,32843,1459,102
31 Dec 13158,18317,38338,05410,966

Quality Earnings: A084110 has high quality earnings.

Growing Profit Margin: A084110 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A084110's earnings have declined by 20% per year over the past 5 years.

Accelerating Growth: A084110 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: A084110 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (22.3%).


Return on Equity

High ROE: A084110's Return on Equity (8.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 07:33
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Huons Global Co., Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyoseob ShinBookook Securities Co. Ltd
JooYong KimKiwoom Securities Co., Ltd.
Eunyoung JungKorea Investment & Securities Co., Ltd.